Loss of prion protein control of glucose metabolism promotes neurodegeneration in model of prion diseases - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue PLoS Pathogens Année : 2021

Loss of prion protein control of glucose metabolism promotes neurodegeneration in model of prion diseases

Declan Williams
Fatima Djouadi
Gerold Schmitt-Ulms

Résumé

Corruption of cellular prion protein (PrP C ) function(s) at the plasma membrane of neurons is at the root of prion diseases, such as Creutzfeldt-Jakob disease and its variant in humans, and Bovine Spongiform Encephalopathies, better known as mad cow disease, in cattle. The roles exerted by PrP C , however, remain poorly elucidated. With the perspective to grasp the molecular pathways of neurodegeneration occurring in prion diseases, and to identify therapeutic targets, achieving a better understanding of PrP C roles is a priority. Based on global approaches that compare the proteome and metabolome of the PrP C expressing 1C11 neuronal stem cell line to those of PrP null -1C11 cells stably repressed for PrP C expression, we here unravel that PrP C contributes to the regulation of the energetic metabolism by orienting cells towards mitochondrial oxidative degradation of glucose. Through its coupling to cAMP/protein kinase A signaling, PrP C tones down the expression of the pyruvate dehydrogenase kinase 4 (PDK4). Such an event favors the transfer of pyruvate into mitochondria and its conversion into acetyl-CoA by the pyruvate dehydrogenase complex and, thereby, limits fatty acids β-oxidation and subsequent onset of oxidative stress conditions. The corruption of PrP C metabolic role by pathogenic prions PrP Sc causes in the mouse hippocampus an imbalance between glucose oxidative degradation and fatty acids β-oxidation in a PDK4-dependent manner. The inhibition of PDK4 extends the survival of prion-infected mice, supporting that PrP Sc -induced deregulation of PDK4 activity and subsequent metabolic derangements contribute to prion diseases. Our study posits PDK4 as a potential therapeutic target to fight against prion diseases.
Fichier principal
Vignette du fichier
journal.ppat.1009991.pdf (1.72 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03413478 , version 1 (10-11-2021)

Identifiants

Citer

Hélène Arnould, Vincent Baudouin, Anne Baudry, Luiz Ribeiro, Hector Ardila-Osorio, et al.. Loss of prion protein control of glucose metabolism promotes neurodegeneration in model of prion diseases. PLoS Pathogens, 2021, 17 (10), pp.e1009991. ⟨10.1371/journal.ppat.1009991⟩. ⟨hal-03413478⟩
56 Consultations
44 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More